Skip to main content
UniHealth

Doctor search

Harvey Abraham Fishman, MD

Ophthalmology · Palo Alto

NPI 1639166838

Medicare standing
1 flag on the record
Listed below.
Plans that list them
Not verified
Not the same as out of network.
Office
1

On the public record

  • Has dropped Medicare — you would pay privately

Offices

1 location

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Fishman’s office at (650) 322-4393 to ask if they take your plan before you enroll.

California Medical Board record

Licence A78707 · Current

Licensed to practise in California · since 2002 · expires 2028-01-31 · Stanford University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Drugs they prescribed that Part D paid

$78,577

Pharmacies billed $78,577 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 316) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

124 generic and 192 brand-name prescriptions · $78,577 in drug cost · 11 antibiotic prescriptions.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Restasis32$23,204$725
Lumigan32$15,513$485
Cyclosporine21$8,066$384
Combigan13$5,339$411
Latanoprost71$376$5
See all 9 drugs
Every Part D drug this clinician prescribed
Restasis32$23,204$725
Lumigan32$15,513$485
Cyclosporine21$8,066$384
Combigan13$5,339$411
Latanoprost71$376$5
Doxycycline Hyclate13$340$26
Erythromycin27$318$12
Timolol Maleate17$232$14
Dorzolamide15$216$14

Year by year

Part D prescribing by year
2024316630% (0)61%$78,577
2023293630% (0)61%$85,100
2022353750% (0)64%$89,329
2021434930% (0)71%$134,740
2020433810% (0)69%$118,508
2019439960% (0)62%$111,713
2018512900% (0)60%$114,882
20174871020% (0)53%$90,734
20165491000% (0)61%$94,987
20155961090% (0)55%$69,235
2014611134None60%$63,857
20139882090% (0)64%$90,501

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 9 drugs

Part D drugs prescribed in 2023
Restasis39$33,034$847
Lumigan36$18,137$504
Alphagan P16$9,056$566
Cyclosporine19$8,711$458
Combigan11$5,938$540
Latanoprost75$658$9
Dorzolamide11$257$23
Erythromycin25$246$10
Timolol Maleate15$177$12

2022: 9 drugs

Part D drugs prescribed in 2022
Restasis39$34,755$891
Lumigan48$18,944$395
Alphagan P27$8,253$306
Vyzulta15$7,311$487
Combigan11$5,935$540
Latanoprost97$1,424$15
Dorzolamide18$451$25
Dorzolamide-Timolol12$304$25
Timolol Maleate15$125$8

2021: 11 drugs

Part D drugs prescribed in 2021
Restasis47$60,057$1,278
Lumigan45$17,570$390
Combigan38$15,459$407
Vyzulta22$12,310$560
Alphagan P27$8,346$309
Simbrinza15$2,784$186
Latanoprost92$2,045$22
Brimonidine12$560$47
Erythromycin34$471$14
Ipratropium13$379$29
Dorzolamide-Timolol11$186$17

2020: 11 drugs

Part D drugs prescribed in 2020
Restasis43$48,044$1,117
Combigan34$14,994$441
Vyzulta26$12,843$494
Lumigan36$12,565$349
Alphagan P22$5,716$260
Azopt13$5,347$411
Simbrinza16$2,820$176
Latanoprost108$2,527$23
Brimonidine12$511$43
Ipratropium11$448$41
Erythromycin26$388$15

2019: 11 drugs

Part D drugs prescribed in 2019
Restasis45$49,036$1,090
Lumigan34$11,563$340
Combigan36$11,285$313
Azasite17$7,557$445
Vyzulta18$7,168$398
Alphagan P25$6,504$260
Azopt11$3,921$356
Latanoprost128$2,760$22
Doxycycline Monohydrate11$489$44
Brimonidine11$348$32
Erythromycin26$273$11

2018: 9 drugs

Part D drugs prescribed in 2018
Restasis50$49,507$990
Lumigan30$11,557$385
Combigan42$9,526$227
Alphagan P30$6,603$220
Azopt12$3,898$325
Simbrinza16$3,050$191
Latanoprost152$2,801$18
Doxycycline Monohydrate22$634$29
Timolol Maleate14$293$21

2017: 9 drugs

Part D drugs prescribed in 2017
Restasis43$35,829$833
Lumigan48$16,350$341
Azasite15$6,446$430
Combigan22$6,265$285
Alphagan P25$5,139$206
Latanoprost140$2,237$16
Valacyclovir12$1,162$97
Doxycycline Monohydrate50$480$10
Erythromycin17$154$9

2016: 12 drugs

Part D drugs prescribed in 2016
Restasis67$39,928$596
Lumigan50$14,783$296
Combigan37$8,348$226
Alphagan P23$4,316$188
Azopt13$3,816$294
Azasite17$3,059$180
Simbrinza13$2,607$201
Cosopt Pf14$2,263$162
Latanoprost149$1,894$13
Doxycycline Monohydrate44$441$10
Timolol Maleate12$185$15
Erythromycin20$174$9

2015: 13 drugs

Part D drugs prescribed in 2015
Restasis60$24,732$412
Lumigan59$11,756$199
Combigan36$6,127$170
Azopt13$3,955$304
Azasite22$2,981$135
Latanoprost228$2,909$13
Alphagan P19$2,272$120
Simbrinza13$1,714$132
Doxycycline Monohydrate24$793$33
Doxycycline Hyclate11$411$37
Timolol Maleate19$299$16
Erythromycin11$126$11
Azithromycin17$116$7

2014: 12 drugs

Part D drugs prescribed in 2014
Restasis55$21,465$390
Lumigan49$8,564$175
Combigan29$5,110$176
Latanoprost231$3,781$16
Doxycycline Monohydrate26$2,922$112
Durezol23$2,859$124
Ilevro17$2,760$162
Besivance21$2,593$123
Azasite20$2,143$107
Vigamox18$1,989$110
Doxycycline Hyclate13$660$51
Timolol Maleate15$150$10

2013: 20 drugs

Part D drugs prescribed in 2013
Restasis54$19,534$362
Vigamox109$11,128$102
Lumigan60$9,525$159
Combigan27$6,490$240
Bromday31$5,325$172
Durezol47$5,217$111
Latanoprost263$5,209$20
Prolensa20$3,536$177
Alphagan P25$3,439$138
Travatan Z14$2,663$190
Azasite25$2,584$103
Bromfenac15$1,690$113
Lotemax11$1,430$130
Prednisolone Acetate74$1,012$14
Ketorolac Tromethamine43$847$20
Brimonidine18$815$45
Dorzolamide-Timolol14$431$31
Timolol Maleate20$343$17
Ciprofloxacin19$292$15
Erythromycin11$181$16

Money from drug and device companies

$67 in 2024

Industry payments by year
202423None$67
202311None$16
202222$2,100$2,120
202134None$67
202023$7,975$7,975
201936$11,362$11,639

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Biotissue HoldingsNone$39
2 payments
  • Meals · 2024-05-12 · $21
  • Meals · 2024-04-15 · $17
AbbvieLumigan$29
1 payment
  • Meals for Lumigan · 2024-11-12 · $29
See all 3 published payments
Every published payment
AbbvieMeals · 2024-11-12Lumigan$29
Biotissue HoldingsMeals · 2024-05-12None$21
Biotissue HoldingsMeals · 2024-04-15None$17
See earlier years (2023, 2022, 2021, 2020, 2019)

2023: $16

Payments by company in 2023
Novartis PharmaceuticalsXiidra$16
1 payment
  • Meals for Xiidra · 2023-08-10 · $16

2022: $2,120

Payments by company in 2022
Lumenis BEOptilight$2,100
1 payment
  • Paid to speak or teach for Optilight · 2022-04-13 · $2,100
Kala PharmaceuticalsInveltys$20
1 payment
  • Meals for Inveltys · 2022-05-19 · $20

2021: $67

Payments by company in 2021
LumenisLumenis Pulse 120h$34
2 payments
  • Meals for Lumenis Pulse 120h · 2021-08-28 · $22
  • Meals for Lumenis Pulse 120h · 2021-08-04 · $12
AllerganDurysta$22
1 payment
  • Meals for Durysta · 2021-02-08 · $22
Novartis PharmaceuticalsXiidra$12
1 payment
  • Meals for Xiidra · 2021-12-09 · $12

2020: $7,975

Payments by company in 2020
LumenisNone$6,750
1 payment
  • Paid to speak or teach · 2020-01-13 · $6,750
Alcon VisionIlux$1,225
1 payment
  • Consulting for Ilux · 2020-06-18 · $1,225

2019: $11,639

Payments by company in 2019
LumenisNone$9,892
1 payment
  • Paid to speak or teach · 2019-02-25 · $9,892
Alcon VisionIlux$1,535
2 payments
  • Consulting for Ilux · 2019-11-08 · $1,470
  • Meals · 2019-10-13 · $65
TissueTechProkera$213
3 payments
  • Meals for Prokera · 2019-10-23 · $56
  • Meals for Prokera · 2019-10-13 · $125
  • Meals for Prokera · 2019-03-22 · $32

Professional record

NPI
1639166838
Licence
CA A78707California A78707: Current · expires 2028-01-31
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207W00000X (207W00000X)
Mailing address
706 Webster St, Palo Alto, CA, 94301
NPI first listed
2005-10-03
NPI last updated
2013-08-26

This is when the NPI record was last certified, not a medical board exam.